These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. 2009 World Congress on the Insulin Resistance Syndrome: cardiovascular disease concepts. Bloomgarden ZT Diabetes Care; 2010 Jul; 33(7):e85-9. PubMed ID: 20587709 [No Abstract] [Full Text] [Related]
24. Cardiovascular risk associated with the metabolic syndrome. Lindsay RS; Howard BV Curr Diab Rep; 2004 Feb; 4(1):63-8. PubMed ID: 14764282 [TBL] [Abstract][Full Text] [Related]
25. The metabolic syndrome and type 2 diabetes: what has gone wrong in type 2 diabetes care? Waldhäusl WK Curr Diab Rep; 2004 Dec; 4(6):395-6. PubMed ID: 15538999 [No Abstract] [Full Text] [Related]
26. The metabolic syndrome: the emperor needs some consistent clothes. Vinicor F; Bowman B Diabetes Care; 2004 May; 27(5):1243; author reply 1244. PubMed ID: 15111565 [No Abstract] [Full Text] [Related]
33. Is this the worst outcome of metabolic syndrome? Hypophosphatemia and resulting cardiac arrest during the treatment of diabetic ketoacidosis with hypertriglyceridemia. Osuka A; Matsuoka T; Idoguchi K Intern Med; 2009; 48(16):1391-5. PubMed ID: 19687585 [TBL] [Abstract][Full Text] [Related]
34. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome. Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S; Mohanty P Curr Mol Med; 2008 Dec; 8(8):816-28. PubMed ID: 19075678 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes. Rosenson RS; Reasner CA Curr Opin Cardiol; 2004 Sep; 19(5):480-7. PubMed ID: 15316457 [TBL] [Abstract][Full Text] [Related]
37. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Cooper SA; Whaley-Connell A; Habibi J; Wei Y; Lastra G; Manrique C; Stas S; Sowers JR Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2009-23. PubMed ID: 17586614 [TBL] [Abstract][Full Text] [Related]
38. Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia. Ayyobi AF; Brunzell JD Am J Cardiol; 2003 Aug; 92(4A):27J-33J. PubMed ID: 12957324 [TBL] [Abstract][Full Text] [Related]
39. Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome. Leung PS; de Gasparo M J Cardiometab Syndr; 2006; 1(3):197-203. PubMed ID: 17679833 [TBL] [Abstract][Full Text] [Related]
40. Calculating insulin resistance in the primary care setting: why should we worry about insulin levels in euglycemic patients? Appel SJ J Am Acad Nurse Pract; 2005 Aug; 17(8):331-6. PubMed ID: 16045594 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]